XML 32 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Financial Instruments
9 Months Ended
Sep. 30, 2018
Fair Value Disclosures [Abstract]  
Financial Instruments
FINANCIAL INSTRUMENTS

The Company's only financial assets and liabilities which are measured at fair value on a recurring basis relate to certain aspects of the Company's benefit plans and our derivative instruments. We use the market approach to value certain assets and liabilities at fair value using significant other observable inputs (Level 2) with the assistance of a third-party specialist. We do not have any assets or liabilities measured at fair value on a recurring basis using quoted prices in an active market (Level 1) or significant unobservable inputs (Level 3). Gains and losses related to the fair value changes in the deferred compensation assets and liabilities are recorded in General and administrative expense in the Consolidated Statements of Operations. Gains and losses related to the fair value of the interest rate swaps are recorded in Other comprehensive income. The following table summarizes the fair value balances (in thousands):
 
 
 
Fair Value Measurement at
 
 
 
September 30, 2018
 
Total
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Deferred compensation assets (1)
$
49,443

 
$

 
$
49,443

 
$

5 year interest rate swap
196

 

 
196

 

10 year interest rate swap
562

 

 
562

 

 
50,201

 

 
50,201

 

Liabilities:
 

 
 

 
 
 
 
Deferred compensation plan
$
40,452

 
$

 
$
40,452

 
$

 
$
40,452

 
$

 
$
40,452

 
$



 
 
 
Fair Value Measurement at
 
 
 
December 31, 2017
 
Total
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Deferred compensation assets (1)
$
46,145

 
$

 
$
46,145

 
$

5 year interest rate swap
70

 

 
70

 

 
$
46,215

 
$

 
$
46,215

 
$

Liabilities:
 

 
 
 
 
 
 
Deferred compensation plan
$
37,280

 
$

 
$
37,280

 
$

10 year interest rate swap
492

 

 
492

 

 
$
37,772

 
$

 
$
37,772

 
$

 
 
 
 
 
 
 
 
(1) Deferred compensation assets consist of the cash surrender value of life insurance policies and are intended to assist in the funding of the deferred compensation agreements.